Table 4.
Risk Score (6-Point Scoring System) | Risk Classification | ||||||
---|---|---|---|---|---|---|---|
Total Points | Patients (n = 146) * |
AEF | Rate of AEF, % | Risk Category | Patients | AEF | Rate of AEF, % (95% CI) |
0 | 15 | 0 | 0.0 | Low risk | 81 | 1 | 1.2 (0–6.7) |
1 | 19 | 1 | 5.3 | ||||
2 | 47 | 0 | 0.0 | ||||
3 | 36 | 5 | 13.9 | High risk | 65 | 21 | 32.3 (21.2–45.0) |
4 | 20 | 7 | 35.0 | ||||
5 | 9 | 9 | 100.0 | ||||
6 | 0 | 0 | NA |
AEF: arterial–esophageal fistula; NA: not applicable; 95% CI: 95% confidence interval; HEARTS-Score consists of hematemesis, active bleeding, renal function (serum creatinine level > 1.2 mg/dL), PT > 13 s, previous stent implantation; low risk is defined as a HEARTS-Score of 0–2 points, while high risk is defined as a HEARTS-Score of 3–6 points. * There were missing data in nine cases.